Investor Relations

Our mission is simple—help patients across the globe who suffer from pain and chronic conditions. We are doing this by harnessing the power of nVNS, innovation, and technology to develop a safe and clinically backed treatment. Bringing new treatments to market will help improve patients' treatment options and lives.

Investor Relations

Data Provided by Refinitiv. Minimum 15 minutes delayed.

News Releases
July 9, 2020
electroCore to Participate in Three Upcoming Virtual Investor Conferences
BASKING RIDGE, N.J. , July 09, 2020 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, announced today that Dan Goldberger , Chief Executive Officer, will participate in three upcoming investor conferences: Maxim Group/M-Vest COVID-19 Virtual

Investor Contact

Investor Relations

Hans Vitzthum, LifeSci Advisors
investors@electrocore.com